CD19 and neoplasm: Flow cytometric analysis of the splenocytes revealed the increased binding of SNA, and AAL to CD3+T cells and CD11b myeloid cells; and increased siglec-1 and AAL binding to the CD19 B cells of the tumor-bearing mice.